TD Asset Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
Other funds holding FOLD
PA
RG
ACA
PAI
TD Asset Management's FOLD Position: Q4 2021 in Review
TD Asset Management sold out of Amicus Therapeutics (FOLD) in Q4 2021, closing a stake of 50,100 shares — an estimated $478K sold.
TD Asset Management first reported a position in FOLD in Q2 2015 and held it in 16 quarters. The position peaked at $3.4M in Q3 2017. 223 funds tracked by Wall St. Rank hold FOLD as of Q4 2021.
- TD Asset Management reported no remaining Amicus Therapeutics position as of Q4 2021 after selling out during the quarter.
- TD Asset Management sold 50,100 Amicus Therapeutics shares in Q4 2021, an estimated $478K.
- TD Asset Management first reported a position in Amicus Therapeutics in Q2 2015 and held it in 16 quarters.
- TD Asset Management's Amicus Therapeutics position peaked at $3.4M in Q3 2017.
- 223 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2021.
Based on TD Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.